Fin Medium

Cadila Healthcare is one of the leading, innovation driven pharmaceutical companies in India and is in the business of -  Research & Development of New Chemical Entities (NCE) Manufacturing, marketing and selling of finished dosage human formulations Generics /  Branded Generics Specialty Formulations Biosimilars Vaccines Active pharmaceutical ingredients (APIs)  Animal healthcare products Consumer wellness products via its subsidiary  Zydus Wellness Limited New Chemical Entities (NCE) New Chemical Entity (NCE) research is characterized by large expenditures, long timelines especially in the late phases of clinical trials, increasingly stringent regulatory environment and the commercialization related uncertainties. The company is working on cutting edge technologies in different scientific disciplines to discover novel therapeutic agents. It has the capabilities to conduct drug discovery and development from concept to Investigational New Drug (IND) enabling pre-clinical and clini

Zydus Wellness is a strong and emerging player in the health and wellness space in India and promoted by Cadila Healthcare Limited (hold 63.55% of shares).  The Company has a wide range of health and wellness products and includes popular brands like Glucon-D, Complan, Sugar Free, Everyuth, Nycil & Nutralite.   Glucon-D has maintained its number one position with a market share of 59.0% Complan has a market share of 5.4% Sugar Free – India’s largest selling low calorie sweetener and has maintained its number one position The Peel Off segment of Everyuth, maintained its number one position with a market share of 77.9% In the Scrub segment, Everyuth maintained its number one position with a market share of 32.5% In the Prickly heat powder category, Nycil maintained its number one position with a market share of 34.4% Moving ahead, the focus is on building the image of Nutralite around its taste and health credentials with more innovations waiting in the pipeline. Health & wellnes